Eudaimonia Asset Management »

Neuropace shares owned by Eudaimonia Asset Management

Quarter-by-quarter ownership of Neuropace (NPCE) shares owned by Eudaimonia Asset Management from 13F filings

Historical chart of Eudaimonia Asset Management investment in Neuropace

Tip: Access up to 7 years of quarterly data

All positions including Neuropace held by Eudaimonia Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neuropace by Eudaimonia Asset Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $1.4M 142k 9.73

More positions owned by Eudaimonia Asset Management

Powell Industries Common Stock (POWL)
Cymabay Therapeutics Common Stock
Aehr Test Systems Common Stock (AEHR)
MiMedx Group Common Stock (MDXG)
Hudson Technologies Common Stock (HDSN)
RxSight Common Stock (RXST)
Applied Optoelectronics Common Stock (AAOI)
Vivo Capital Common Stock (SLNO)
Gambling.com Group Common Stock (GAMB)
Limbach Holdings Common Stock (LMB)
Roivant Sciences Common Stock (IMVT)
Arlo Technologies Common Stock (ARLO)
PetIQ Common Stock (PETQ)
Newpark Resources Common Stock (NR)
Avita Medical Common Stock (RCEL)

View all positions for Eudaimonia Asset Management

Top funds holding Neuropace

OrbiMed Advisors
Soleus Capital Management
Nantahala Capital Management
Kent Lake Capital
Vanguard Group
Millennium Management
Jane Street
Citigroup
Bank of America Corporation
Balyasny Asset Management
683 Capital Management
Citadel Advisors
Laurion Capital Management
Man Group
Townsquare Capital

View all funds holding Neuropace